Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery

PHASE3RecruitingINTERVENTIONAL
Enrollment

166

Participants

Timeline

Start Date

February 3, 2025

Primary Completion Date

February 1, 2026

Study Completion Date

June 1, 2026

Conditions
Postoperative Urinary Retention (POUR)
Interventions
DRUG

Tamsulosin

This intervention will investigate if tamsulosin will decrease postoperative urinary retention. Subjects will be directed to start taking the medication 5-7 days prior to their procedure; as previous studies have shown, this is when tamsulosin reaches its steady state. Patients will continue to take their assigned pills for 7 days postoperatively.

DRUG

Placebo

This intervention will ensure blinding and an accurate measure of the real effect of tamsulosin.

Trial Locations (1)

45220

RECRUITING

TriHealth, Cincinnati

All Listed Sponsors
lead

TriHealth Inc.

OTHER